Two clinical-stage biopharmaceutical companies, one focused on the development of new drugs for the treatment of neuropsychiatric disorders and one dedicated to developing protein therapeutics for the treatment of cancer as well as for autoimmune and inflammatory diseases, are two stocks that analysts at Wells Fargo – as well as the broader analyst community – believe could jump from current levels. In fact, one of these stocks is the firm’s top idea in 2021! For these two stocks, CLICK HERE.
2 Biotech Stocks That Could Be Ready To Jump – Including Wells Fargo’s Top Idea In 2021!
- by RobH
Tags:Biopharmaceutical StocksBiotech StocksClinical-Stage Biopharmaceutical CompaniesInvestment OpportunitiesInvestorProtein TherapeuticsTop Stocks 2021Wells Fargo